These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 790170

  • 1. Serotonin and myoclonus.
    Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB.
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [Abstract] [Full Text] [Related]

  • 2. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH, Rosenbaum D, Howieson J, Bowers MB.
    N Engl J Med; 1977 Jan 13; 296(2):70-5. PubMed ID: 401457
    [Abstract] [Full Text] [Related]

  • 3. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ, Sharpless NS, Wolfson L, Katzman R.
    Ann Neurol; 1980 Jun 13; 7(6):570-6. PubMed ID: 6969054
    [Abstract] [Full Text] [Related]

  • 4. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L, Sharpless N, Wolfson L, Engel J, Katzman R.
    Trans Am Neurol Assoc; 1976 Jun 13; 101():48-52. PubMed ID: 1088459
    [No Abstract] [Full Text] [Related]

  • 5. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH, Sethy VH.
    Neurology; 1975 Feb 13; 25(2):135-40. PubMed ID: 1078720
    [Abstract] [Full Text] [Related]

  • 6. The indoleamine hypothesis of depression: an overview and pilot study.
    Zarcone VP, Berger PA, Brodie KH, Sack R, Barchas JD.
    Dis Nerv Syst; 1977 Aug 13; 38(8):646-53. PubMed ID: 328245
    [Abstract] [Full Text] [Related]

  • 7. [Serotoninergic conception of myoclonic syndromes. (Review)].
    Levin SL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979 Aug 13; 79(6):797-803. PubMed ID: 224629
    [No Abstract] [Full Text] [Related]

  • 8. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
    Sternberg EM, Van Woert MH, Young SN, Magnussen I, Baker H, Gauthier S, Osterland CK.
    N Engl J Med; 1980 Oct 02; 303(14):782-7. PubMed ID: 6997735
    [Abstract] [Full Text] [Related]

  • 9. Study of serotonin in neuropsychiatric disorders.
    Van Woert MH, Magnussen I, Lowe YH, Hwang EC.
    J Histochem Cytochem; 1982 Aug 02; 30(8):824-7. PubMed ID: 6181125
    [No Abstract] [Full Text] [Related]

  • 10. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J, Richardson JC, Hornykiewicz O.
    Neurology; 1976 Sep 02; 26(9):863-8. PubMed ID: 1084968
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR, Huang Y, Tate E, Stanley M, Noetzel MJ, Gospe SM, Banasiak K.
    Ann Neurol; 1995 Feb 02; 37(2):189-97. PubMed ID: 7531417
    [Abstract] [Full Text] [Related]

  • 12. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
    Growdon JH, Young RR, Shahani BT.
    Neurology; 1976 Dec 02; 26(12):1135-40. PubMed ID: 1086988
    [Abstract] [Full Text] [Related]

  • 13. Manipulation of brain serotonin in the treatment of myoclonus.
    Chadwick D, Jenner P, Harris R, Reynolds EH, Marsden CD.
    Lancet; 1975 Sep 06; 2(7932):434-5. PubMed ID: 51240
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine in the treatment of intention myoclonus.
    Van Woert MH, Magnussen I, Rosenbaum D, Chung E.
    Clin Neuropharmacol; 1983 Mar 06; 6(1):49-54. PubMed ID: 6189599
    [Abstract] [Full Text] [Related]

  • 15. Serotoninergic dysfunction in the 47, XYY syndrome.
    Bioulac B, Benezech M, Renaud B, Noel B, Roche D.
    Biol Psychiatry; 1980 Dec 06; 15(6):917-23. PubMed ID: 6161648
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
    Guilleminault C, Tharp BR, Cousin D.
    J Neurol Sci; 1973 Apr 06; 18(4):435-41. PubMed ID: 4540626
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D, Hallett M, Harris R, Jenner P, Reynolds EH, Marsden CD.
    Brain; 1977 Sep 06; 100(3):455-87. PubMed ID: 412560
    [Abstract] [Full Text] [Related]

  • 20. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH.
    Prog Clin Biol Res; 1983 Sep 06; 127():43-52. PubMed ID: 6351100
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.